Methimazole-induced bone marrow aplasia;Anemia aplastica indotta da metimazolo

Recenti Progressi in Medicina

Volumn 90, Issue 9, 1999, Pages 470-472

  Mechelli, Sandra ^a   Bolognesi, Sergio ^a   Siuti, Elena ^a   Stefanelli, Alessandro ^a   Castiglioni, Maido Giovacchino ^a  

^a CISANELLO HOSPITAL   (Italy)

Author keywords

Antithyroid drug; Aplastic anemia; Hyperthyroidism; Tapazole

Indexed keywords

DANAZOL; IMMUNOGLOBULIN G; METHYLPREDNISOLONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THIAMAZOLE;

AGED; ARTICLE; BONE MARROW APLASIA; BONE MARROW TOXICITY; CASE REPORT; CHRONIC KIDNEY FAILURE; DOSE RESPONSE; DRUG CONTRAINDICATION; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTHYROIDISM; INTRAVENOUS DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PROGNOSIS;

ADULT; AGED; ANEMIA, APLASTIC; ANTI-INFLAMMATORY AGENTS; ANTITHYROID AGENTS; DANAZOL; ESTROGEN ANTAGONISTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTHYROIDISM; IMMUNOGLOBULINS, INTRAVENOUS; MALE; METHIMAZOLE; METHYLPREDNISOLONE; MIDDLE AGED; TIME FACTORS;

EID: 0032839617     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. Cooper DS. Antityroid drugs. N Engl J Med 1984; 311: 1353-1362.
2. Mc Kenzie JM, Zakarija M. Hypertyroidim. In: De Groot LJ. Chaill GF Jr, Martini L, et al. (eds). Endocrinology. New York: Grune and Stratton 1979: 1: 429-459.
3. Edel SL, Bartuska DG Aplastic anemia secondary to methimazole: case report and review of hematologic side effects. J Am Med Worn Asst 1975; 30: 412-123.
4. Bismwas N, Ahn YH, Goldman JM, Schwarts JM. Aplastic anemia associated with antityroid drugs. Am J Med Sci 1991; 301: 190-194.
5. Moreb J, Shemesh O, Shilo S, Manor C, Hreshko C. Transiet methimazole-induced bone marrow aplasia: in vitro evidence for a humoral mechanism of bone marrow suppression. Acta Haemat 1983; 69: 127-131.
6. Riccioni N, Castiglioni MG, Roni P. Small starting dose of methimazole in thyrotoxicosis. Lancet 1979; 1: 1087-1088.
7. Duglas SR. Hyperthyroidism. In: Rakel RE, ed. Conn Current Therapy. Philadelphia: Saunders 1997; 638-642.
8. Macia M, Mundex M, Fernandez J, Rivero Rios A. Severe pancytopenia associated with antityroid drugs in a patient with Grave's disease and chronic renal failure. Clinical Nephrol 1997; 47: 129.